Ownership history in NATIXIS · 7 quarters on record
This page tracks every 13F SEC filing in which NATIXIS reported a position in TRAVERE THERAPEUTICS INC (TVTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 3,212 | -160,288 | -98.0% | 0.00% | $77K | $23.90 |
| 2023 Q3 | ADDED | 163,500 | +28,500 | +21.1% | 0.01% | $1.5M | $8.94 |
| 2023 Q2 | ADDED | 135,000 | +94,700 | +235.0% | 0.02% | $2.1M | $15.36 |
| 2023 Q1 | REDUCED | 40,300 | -59,700 | -59.7% | 0.01% | $906K | $22.49 |
| 2022 Q4 | UNCHANGED | 100,000 | — | 0% | 0.00% | $2.1M | $21.03 |
| 2022 Q3 | ADDED | 100,000 | +34,608 | +52.9% | 0.01% | $2.6M | $24.64 |
| 2022 Q1 | INITIATED | 65,392 | — | — | 0.01% | $1.7M | $25.77 |
As of 2025 Q4 — sorted by position size